Skip to main content

Peer Review reports

From: Monitoring of T790M in plasma ctDNA of advanced EGFR-mutant NSCLC patients on first- or second-generation tyrosine kinase inhibitors

Original Submission
7 Jan 2023 Submitted Original manuscript
22 Jan 2023 Reviewed Reviewer Report
9 Feb 2023 Reviewed Reviewer Report
23 Feb 2023 Author responded Author comments - Chao-Chi Ho
Resubmission - Version 2
23 Feb 2023 Submitted Manuscript version 2
2 Mar 2023 Editorially accepted
13 Mar 2023 Article published 10.1186/s12885-023-10698-5

You can find further information about peer review here.

Back to article page